SCHEMBL723341

SCHEMBL723341

Fc1cccc(C(Br)Br)c1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
IDO1 P14902 1/20 0.47
TDO2 P48775 1/20 0.47
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
ACHE P22303 1/20 0.42
NFE2L2 Q16236 1/20 0.41
AOC3 Q16853 1/20 0.41
CNR2 P34972 1/20 0.39
CYP19A1 P11511 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433928 0.85 HDAC4 (0.47) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL6204304 0.83 HDAC4 (0.50) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL3808194 0.83 HDAC4 (0.46) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL11211102 0.82 SLC6A4 (0.40) IDO1TDO2
SCHEMBL2253545 0.81 CES2 (0.52) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL508509 0.81 ACHE (0.44) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL4975530 0.81 ACHE (0.44) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL30076024 0.81 ACHE (0.44) HDAC4HDAC7HDAC5IDO1TDO2
SCHEMBL5250314 0.81 PGK1 (0.42) HDAC4IDO1TDO2CES2CES1
SCHEMBL7519538 0.79 IDO1 (0.52) HDAC4HDAC7HDAC5IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680602-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS Miralinc Pharma, Inc. (US) 2026-01-21 EP disclosed
CN-113135937-B Fused tetracyclic compound and application thereof in medicines 广东东阳光药业股份有限公司 2024-11-08 CN disclosed
WO-2024192237-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS MIRALINC PHARMA, INC. (US) 2024-09-19 WO disclosed
WO-2024107763-A1 N6-ADENOSINE-METHYLTRANSFERASE PROTACS AND METHODS OF USE THEREOF UNIVERSITY OF ZURICH (CH) 2024-05-23 WO disclosed
WO-2023222762-A1 N6-ADENOSINE-METHYLTRANSFERASE PROTACS AND METHODS OF USE THEREOF UNIVERSITY OF ZURICH (CH) 2023-11-23 WO disclosed
CN-110981679-B Method for producing halogenated compound and fullerene derivative 昭和电工株式会社 2023-02-17 CN disclosed
EP-3489569-B1 GAS SUPPLY APPARATUS AND GAS SUPPLY METHOD SHOWA DENKO KK (JP) 2023-01-18 EP disclosed
US-11427907-B2 Gas supply apparatus and gas supply method SHOWA DENKO K.K. (JP) 2022-08-30 US disclosed
US-20220251703-A1 GAS SUPPLY APPARATUS AND GAS SUPPLY METHOD SHOWA DENKO K.K. (JP) 2022-08-11 US disclosed
CN-109477613-B Gas supply device and gas supply method 昭和电工株式会社 2021-11-19 CN disclosed
EP-0759026-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1997-02-26 EP disclosed
WO-1995030645-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1995-11-16 WO disclosed
EP-0420941-B1 PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES ALLIED SIGNAL INC (US) 1994-01-12 EP disclosed
EP-0238753-B1 N-SUBSTITUTED CONDENSED POLYMETHYLENE IMINE DERIVATIVES BEECHAM GROUP PLC (GB) 1992-01-15 EP disclosed
EP-0420941-A1 PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES. ALLIED SIGNAL INC (US) 1991-04-10 EP disclosed
US-4959374-A HYPOTENSIVE AGENTS, ANTICOAGULANTS, GLAUCOMA, HYPERGLYCEMIC AGENTS, ANTIDEPRESSANTS BEECHAM GROUP P.L.C. (GB) 1990-09-25 US disclosed
US-4922017-A Process for production of aromatic aldoximes ALLIED-SIGNAL INC. (US) 1990-05-01 US disclosed
WO-1989012623-A1 PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES ALLIED-SIGNAL INC. (US) 1989-12-28 WO disclosed
US-4863946-A HYPOGLYCEMIC AND HYPOTENSIVE AGENTS BEECHAM GROUP PLC (GB) 1989-09-05 US disclosed
EP-0238753-A1 N-substituted condensed polymethylene imine derivatives BEECHAM GROUP PLC (GB) 1987-09-30 EP disclosed